Spicamycin (1) is a mixture of several related components that differ only in the nature of their fatty acid moieties. The mixture is produced by Streptomyces alanosinicus 879-MT3, and was isolated as a differentiation inducer of mouse myeloid leukemia cells (Ml) and human promyelocytic leukemia cells (HL-60)1>2). It also showed antitumor activity against P388 leukemia in mice.
alanosinicus 879-MT3, and was isolated as a differentiation inducer of mouse myeloid leukemia cells (Ml) and human promyelocytic leukemia cells (HL-60)1>2). It also showed antitumor activity against P388 leukemia in mice.
By preparation of several semi-synthetic spicamycin analogues which differed in the length of the fatty acid moiety, we found that the dodecanoyl analogue showed an excellent activity against human gastric cancer SC-9 in the humanxenograft model3). Since the relative configuration at C-6' and the absolute configuration of their interesting compoundsremained unknown,we have attempted to solve these problems by The H atom positions except those of the methanol solvate were located from a difference Fourier synthesis. All non-hydrogen atoms were refined anisotropically and H atoms isotropically.
The final R and Rwvalues were 0.054 and 0.057, respectively. The source of scattering factor data was given by the International Tables for X-ray Crystallography (1974)6). Crystallographic calculations were performed on a FACOM M-1800 computer using UNICS-III program system7). In the crystals, the molecules are linked by an intermolecular hydrogen bond O6-H à"à"-N4'1, 2.836(6)A, 176(8)°where i is 
